Year |
Citation |
Score |
2021 |
Tadinada SM, Weatherford ET, Collins GV, Bhardwaj G, Cochran J, Kutschke W, Zimmerman K, Bosko A, O'Neill BT, Weiss RM, Abel ED. FUNCTIONAL RESILIENCE OF C57BL/6J MOUSE HEART TO DIETARY FAT OVERLOAD. American Journal of Physiology. Heart and Circulatory Physiology. PMID 34477461 DOI: 10.1152/ajpheart.00419.2021 |
0.301 |
|
2021 |
Abel ED. Insulin signaling in the heart. American Journal of Physiology. Endocrinology and Metabolism. 321: E130-E145. PMID 34056923 DOI: 10.1152/ajpendo.00158.2021 |
0.31 |
|
2021 |
Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac Energy Metabolism in Heart Failure. Circulation Research. 128: 1487-1513. PMID 33983836 DOI: 10.1161/CIRCRESAHA.121.318241 |
0.3 |
|
2020 |
Zhang Y, Taufalele PV, Cochran JD, Robillard-Frayne I, Marx JM, Soto J, Rauckhorst AJ, Tayyari F, Pewa AD, Gray LR, Teesch LM, Puchalska P, Funari TR, McGlauflin R, Zimmerman K, ... ... Abel ED, et al. Mitochondrial pyruvate carriers are required for myocardial stress adaptation. Nature Metabolism. PMID 33106689 DOI: 10.1038/s42255-020-00288-1 |
0.324 |
|
2020 |
Brahma MK, Ha CM, Pepin ME, Mia S, Sun Z, Chatham JC, Habegger KM, Abel ED, Paterson AJ, Young ME, Wende AR. Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization. Journal of the American Heart Association. 9: e013039. PMID 32750298 DOI: 10.1161/Jaha.119.013039 |
0.352 |
|
2020 |
Wende AR, Schell JC, Ha CM, Pepin ME, Khalimonchuk O, Schwertz H, Pereira RO, Brahma MK, Tuinei J, Contreras-Ferrat A, Wang L, Andrizzi CA, Olsen CD, Bradley WE, Dell'Italia LJ, ... ... Abel ED, et al. Maintaining Myocardial Glucose Utilization in Diabetic Cardiomyopathy Accelerates Mitochondrial Dysfunction. Diabetes. PMID 32366681 DOI: 10.2337/db19-1057 |
0.345 |
|
2020 |
Riehle C, Weatherford ET, Wende AR, Jaishy BP, Seei AW, McCarty NS, Rech M, Shi Q, Reddy GR, Kutschke WJ, Oliveira K, Pires KM, Anderson JC, Diakos NA, Weiss RM, ... ... Abel ED, et al. Insulin receptor substrates differentially exacerbate insulin-mediated left ventricular remodeling. Jci Insight. 5. PMID 32213702 DOI: 10.1172/Jci.Insight.134920 |
0.312 |
|
2020 |
Jensen RD, Peterson J, Allington B, Dieter A, Cheng L, Soto J, Alambert RP, Correia M, Abel ED. SUN-LB118 Mice With Skeletal Muscle-Specific DRP1 Deficiency Are Resistant to Obesity and Diabetes Induced by a High Fat Diet Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.2320 |
0.302 |
|
2018 |
Fidler TP, Marti AP, Gerth K, Rondina MT, Weyrich AS, Abel ED. Abstract 016: Glucose Metabolism is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes Mellitus Arteriosclerosis, Thrombosis, and Vascular Biology. 38. DOI: 10.1161/Atvb.38.Suppl_1.016 |
0.312 |
|
2017 |
Wende AR, Kim J, Holland W, Wayment BE, O'Neill BT, Tuinei J, Brahma MK, Pepin ME, McCrory MA, Luptak I, Halade GV, Litwin SE, Abel ED. Glucose transporter 4 (GLUT4) deficient hearts develop maladaptive hypertrophy in response to physiologic or pathologic stresses. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00101.2017. PMID 28822962 DOI: 10.1152/ajpheart.00101.2017 |
0.305 |
|
2017 |
Rines AK, Chang HC, Wu R, Sato T, Khechaduri A, Kouzu H, Shapiro J, Shang M, Burke MA, Jiang X, Chen C, Rawlings TA, Lopaschuk GD, Schumacker PT, Abel ED, et al. Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling. Nature Communications. 8: 14095. PMID 28117339 DOI: 10.1038/Ncomms14095 |
0.32 |
|
2016 |
Riehle C, Abel ED. Insulin Signaling and Heart Failure. Circulation Research. 118: 1151-69. PMID 27034277 DOI: 10.1161/CIRCRESAHA.116.306206 |
0.312 |
|
2015 |
Ni R, Zheng D, Xiong S, Hill DJ, Sun T, Gardiner RB, Fan GC, Lu Y, Abel ED, Greer PA, Peng T. Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type-1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy. Diabetes. PMID 26470784 DOI: 10.2337/Db15-0963 |
0.3 |
|
2015 |
Ilkun O, Wilde N, Tuinei J, Pires KM, Zhu Y, Bugger H, Soto J, Wayment B, Olsen C, Litwin SE, Abel ED. Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome. Journal of Molecular and Cellular Cardiology. 85: 104-16. PMID 26004364 DOI: 10.1016/j.yjmcc.2015.05.012 |
0.367 |
|
2015 |
Koentges C, König A, Pfeil K, Hölscher ME, Schnick T, Wende AR, Schrepper A, Cimolai MC, Kersting S, Hoffmann MM, Asal J, Osterholt M, Odening KE, Doenst T, Hein L, ... Abel ED, et al. Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1. Basic Research in Cardiology. 110: 37. PMID 25982881 DOI: 10.1007/S00395-015-0495-4 |
0.305 |
|
2014 |
Pereira RO, Wende AR, Olsen C, Soto J, Rawlings T, Zhu Y, Riehle C, Abel ED. GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure Journal of Molecular and Cellular Cardiology. 72: 95-103. PMID 24583251 DOI: 10.1016/j.yjmcc.2014.02.011 |
0.301 |
|
2014 |
Lopez-Izquierdo A, Pereira RO, Wende AR, Punske BB, Abel ED, Tristani-Firouzi M. The absence of insulin signaling in the heart induces changes in potassium channel expression and ventricular repolarization. American Journal of Physiology. Heart and Circulatory Physiology. 306: H747-54. PMID 24375641 DOI: 10.1152/ajpheart.00849.2013 |
0.328 |
|
2014 |
Parra V, Verdejo HE, Iglewski M, Del Campo A, Troncoso R, Jones D, Zhu Y, Kuzmicic J, Pennanen C, Lopez-Crisosto C, Jaña F, Ferreira J, Noguera E, Chiong M, Bernlohr DA, ... ... Abel ED, et al. Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathway. Diabetes. 63: 75-88. PMID 24009260 DOI: 10.2337/Db13-0340 |
0.303 |
|
2013 |
Zhu Y, Soto J, Anderson B, Riehle C, Zhang YC, Wende AR, Jones D, McClain DA, Abel ED. Regulation of fatty acid metabolism by mTOR in adult murine hearts occurs independently of changes in PGC-1α. American Journal of Physiology. Heart and Circulatory Physiology. 305: H41-51. PMID 23624629 DOI: 10.1152/ajpheart.00877.2012 |
0.338 |
|
2013 |
Sohn K, Wende AR, Abel ED, Moreno AP, Sachse FB, Punske BB. Absence of glucose transporter 4 diminishes electrical activity of mouse hearts during hypoxia. Experimental Physiology. 98: 746-57. PMID 23180812 DOI: 10.1113/Expphysiol.2012.070235 |
0.314 |
|
2012 |
Boudina S, Han YH, Pei S, Tidwell TJ, Henrie B, Tuinei J, Olsen C, Sena S, Abel ED. UCP3 regulates cardiac efficiency and mitochondrial coupling in high fat-fed mice but not in leptin-deficient mice. Diabetes. 61: 3260-9. PMID 22912419 DOI: 10.2337/db12-0063 |
0.304 |
|
2012 |
Abel ED, O'Shea KM, Ramasamy R. Insulin resistance: Metabolic mechanisms and consequences in the heart Arteriosclerosis, Thrombosis, and Vascular Biology. 32: 2068-2076. PMID 22895668 DOI: 10.1161/Atvbaha.111.241984 |
0.335 |
|
2012 |
Bugger H, Riehle C, Jaishy B, Wende AR, Tuinei J, Chen D, Soto J, Pires KM, Boudina S, Theobald HA, Luptak I, Wayment B, Wang X, Litwin SE, Weimer BC, ... Abel ED, et al. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes. Journal of Molecular and Cellular Cardiology. 52: 1019-26. PMID 22342406 DOI: 10.1016/J.Yjmcc.2012.02.001 |
0.335 |
|
2011 |
Sloan C, Tuinei J, Nemetz K, Frandsen J, Soto J, Wride N, Sempokuya T, Alegria L, Bugger H, Abel ED. Central leptin signaling is required to normalize myocardial fatty acid oxidation rates in caloric-restricted ob/ob mice. Diabetes. 60: 1424-34. PMID 21441440 DOI: 10.2337/db10-1106 |
0.304 |
|
2010 |
Wende AR, Soto J, Olsen CD, Pires KM, Schell JC, Larrieu-Lahargue F, Litwin SE, Kakoki M, Takahashi N, Smithies O, Abel ED. Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice. Endocrinology. 151: 3536-42. PMID 20501666 DOI: 10.1210/En.2010-0256 |
0.311 |
|
2009 |
Sena S, Hu P, Zhang D, Wang X, Wayment B, Olsen C, Avelar E, Abel ED, Litwin SE. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. Journal of Molecular and Cellular Cardiology. 46: 910-8. PMID 19249310 DOI: 10.1016/j.yjmcc.2009.02.014 |
0.302 |
|
2009 |
Boudina S, Bugger H, Sena S, O'Neill BT, Zaha VG, Ilkun O, Wright JJ, Mazumder PK, Palfreyman E, Tidwell TJ, Theobald H, Khalimonchuk O, Wayment B, Sheng X, Rodnick KJ, ... ... Abel ED, et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation. 119: 1272-83. PMID 19237663 DOI: 10.1161/CIRCULATIONAHA.108.792101 |
0.323 |
|
2008 |
Augustus AS, Buchanan J, Gutman E, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism Cell Cycle. 7: 2509-2518. PMID 18719368 DOI: 10.4161/Cc.7.16.6421 |
0.305 |
|
2008 |
Bugger H, Boudina S, Hu XX, Tuinei J, Zaha VG, Theobald HA, Yun UJ, McQueen AP, Wayment B, Litwin SE, Abel ED. Type 1 diabetic akita mouse hearts are insulin sensitive but manifest structurally abnormal mitochondria that remain coupled despite increased uncoupling protein 3. Diabetes. 57: 2924-32. PMID 18678617 DOI: 10.2337/db08-0079 |
0.323 |
|
2008 |
Augustus AS, Buchanan J, Addya S, Rengo G, Pestell RG, Fortina P, Koch WJ, Bensadoun A, Abel ED, Lisanti MP. Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts American Journal of Physiology - Heart and Circulatory Physiology. 295: H657-H666. PMID 18552160 DOI: 10.1152/Ajpheart.00387.2008 |
0.309 |
|
2008 |
Tabbi-Anneni I, Buchanan J, Cooksey RC, Abel ED. Captopril normalizes insulin signaling and insulin-regulated substrate metabolism in obese (ob/ob) mouse hearts. Endocrinology. 149: 4043-50. PMID 18450963 DOI: 10.1210/en.2007-1646 |
0.332 |
|
2008 |
Bugger H, Abel ED. Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clinical Science (London, England : 1979). 114: 195-210. PMID 18184113 DOI: 10.1042/CS20070166 |
0.316 |
|
2007 |
Sena S, Rasmussen IR, Wende AR, McQueen AP, Theobald HA, Wilde N, Pereira RO, Litwin SE, Berger JP, Abel ED. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling. Endocrinology. 148: 6047-53. PMID 17823261 DOI: 10.1210/EN.2006-1559 |
0.306 |
|
2007 |
Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX, Aziz S, Johnson JI, Bugger H, Zaha VG, Abel ED. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes. 56: 2457-66. PMID 17623815 DOI: 10.2337/db07-0481 |
0.301 |
|
2006 |
Boudina S, Abel ED. Mitochondrial uncoupling: a key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda, Md.). 21: 250-8. PMID 16868314 DOI: 10.1152/PHYSIOL.00008.2006 |
0.303 |
|
2006 |
Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, Zaha VG, Dyck JR, Abel ED, Young ME. Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin. American Journal of Physiology. Heart and Circulatory Physiology. 290: H2480-97. PMID 16428347 DOI: 10.1152/ajpheart.01344.2005 |
0.311 |
|
2006 |
Augustus AS, Buchanan J, Park TS, Hirata K, Noh HL, Sun J, Homma S, D'armiento J, Abel ED, Goldberg IJ. Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction. The Journal of Biological Chemistry. 281: 8716-23. PMID 16410253 DOI: 10.1074/Jbc.M509890200 |
0.333 |
|
2005 |
McQueen AP, Zhang D, Hu P, Swenson L, Yang Y, Zaha VG, Hoffman JL, Yun UJ, Chakrabarti G, Wang Z, Albertine KH, Abel ED, Litwin SE. Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density. Journal of Molecular and Cellular Cardiology. 39: 882-92. PMID 16216265 DOI: 10.1016/j.yjmcc.2005.07.017 |
0.307 |
|
2005 |
Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology. 146: 5341-9. PMID 16141388 DOI: 10.1210/en.2005-0938 |
0.306 |
|
2005 |
Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Current Drug Targets. Immune, Endocrine and Metabolic Disorders. 5: 219-26. PMID 16089356 DOI: 10.2174/1568008054064869 |
0.338 |
|
2005 |
Abel ED. Insulin signaling in heart muscle: lessons from genetically engineered mouse models. Current Hypertension Reports. 6: 416-23. PMID 15527684 DOI: 10.1007/S11906-004-0034-4 |
0.308 |
|
2004 |
Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes. 53: 2366-74. PMID 15331547 DOI: 10.2337/diabetes.53.9.2366 |
0.328 |
|
2002 |
Belke DD, Betuing S, Tuttle MJ, Graveleau C, Young ME, Pham M, Zhang D, Cooksey RC, McClain DA, Litwin SE, Taegtmeyer H, Severson D, Kahn CR, Abel ED. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. The Journal of Clinical Investigation. 109: 629-39. PMID 11877471 DOI: 10.1172/Jci13946 |
0.345 |
|
1999 |
Abel ED, Kaulbach HC, Tian R, Hopkins JC, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. The Journal of Clinical Investigation. 104: 1703-14. PMID 10606624 DOI: 10.1172/Jci7605 |
0.333 |
|
Show low-probability matches. |